Article 23 Oct 2026 CMS Finalizes Mandatory GLOBE Model Implementing Most Favored Nation Drug Pricing In Medicare Part B United States Healthcare
Article 07 Aug 2026 HRSA Announces Updated 340B Rebate Model Pilot Program, Limited To Drugs Subject To A Maximum Fair Price (MFP) For 2026 And 2027 United States Finance
Article 23 Jul 2026 CMS Issues Proposed Guidance Governing Maximum Fair Price Effectuation For IPAY 2028, With A Focus On Part B Drugs United States Finance